Cost-Minimization Analysis of Panitumumab Compared with Cetuximab in the First-Line Treatment of Wild-Type RAS Metastatic Colorectal Cancer Patients in Brazil
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2242
https://www.valueinhealthjournal.com/article/S1098-3015(16)33608-7/fulltext
Title :
Cost-Minimization Analysis of Panitumumab Compared with Cetuximab in the First-Line Treatment of Wild-Type RAS Metastatic Colorectal Cancer Patients in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33608-7&doi=10.1016/j.jval.2016.09.2242
First page :
A738
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2123